Abstract
Introduction: Lumacaftor/ivacaftor (LUM/IVA) has been shown to improve clinical outcomes in cystic fibrosis (CF) patients homozygous for Phe508del wit......
小提示:本篇文献需要登录阅读全文,点击跳转登录